...
首页> 外文期刊>Emerging Infectious Diseases >Persistent Extended-Spectrum β-Lactamase Urinary Tract Infection
【24h】

Persistent Extended-Spectrum β-Lactamase Urinary Tract Infection

机译:持久性广谱β-内酰胺酶尿路感染

获取原文

摘要

To the Editor: Uncomplicated urinary tract infections (UTIs) in oth-erwise healthy adults are usually treat-ed empirically because the causative microbe is highly predictable: 80%–90% are caused by Escherichia coli. In addition, short courses of therapy (1 day or 3 days) are usually complet-ed before laboratory results become available. In the past decade, reports of community-acquired, extended-spectrum β-lactamase (ESBL)–pro-ducing E. coli isolates have increased worldwide, but they are still uncom-mon in the United States (1), where re-ported cases are generally associated with hospitals. An early report of true community-acquired ESBL-producing E. coli infections in the United States was published in 2007 (2). We report a case of community-acquired lower UTI caused by ESBL-producing and multidrug resistant E. coli in an oth-erwise healthy college-aged woman who had no hospital exposure. De-spite proper treatment, her infection persisted subclinically and symptoms recurred 2 months later
机译:致编辑:在其他健康成年人中,单纯并发症的尿路感染(UTI)通常凭经验进行治疗,因为病原微生物是可以高度预测的:80%至90%是由大肠杆菌引起的。此外,通常在完成实验室检查结果之前就完成短期治疗(1天或3天)。在过去的十年中,全球范围内产生社区获得的广谱β-内酰胺酶(ESBL)大肠杆菌分离株的报道有所增加,但在美国仍然不常见(1),在美国移植病例通常与医院有关。 2007年,美国发表了一份关于在社区中真正获得ESBL感染的大肠杆菌的真实报告(2)。我们报道了另一例健康正常的大学时代女性的ESL产生和多药耐药性大肠杆菌引起的社区获得性UTI降低,该女性没有医院暴露。尽管进行了适当的治疗,她的感染仍在亚临床上持续存在,并且两个月后症状再次出现

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号